Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2016 | Antifungal prophylaxis in leukemia patients

Antonio Pagliuca • 4 Apr 2016
EBMT 2016
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia

At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio Pagliuca, MD from King’s College Hospital, London, UK discusses antifungal prophylaxis in leukemia patients. With therapies focused mainly on disease relapse it is important to remember that morbidity and mortality of fungal disease is significant.

More from Antonio Pagliuca

1:40
The future of immunotherapy
Antonio Pagliuca • 28 Feb 2019
1:18
Working together - CAR T-cell logistics
Antonio Pagliuca • 28 Feb 2019
1:27
CAR T-cell therapy's rapid entrance
Antonio Pagliuca • 28 Feb 2019
1:54
Reflections on an excellent EBMT 2018
Antonio Pagliuca • 17 Mar 2018

Related Videos

3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals